Updates on the Potential Role of ctDNA in Managing Breast Cancer Patients Across the Disease Continuum

Expert oncologist Aditya Bardia, MD, MPH, provides a broad overview of minimal residual disease testing across a number of tumor types and clinical settings.

Barry Rosen, MD, provides an overview of circulating tumor DNA’s role in early stage breast cancer detection and management.

Aditya Bardia, MD, MPH, shares insight on how circulating tumor DNA is used in metastatic breast cancer and relapse detection.

Expert perspectives on the value of circulating tumor DNA in the neoadjuvant setting of breast cancer management.

Aditya Bardia, MD, MPH, and Barry Rosen, MD, discuss the role of circulating tumor DNA in the adjuvant setting of breast cancer.

A brief synopsis on the use of circulating tumor DNA for cancer detection versus treatment selection in breast cancer management.

Shared insight on how clinical trial data behind circulating tumor DNA in breast cancer may affect future treatment strategies.

Closing out their discussion on circulating tumor DNA in breast cancer management, experts share closing advice on practical strategies to use testing in clinic.